Restricted accessResearch articleFirst published online 2015-08
RELB Alters Proliferation of Human Pluripotent Stem Cells via IMP3- and LIN28-Mediated Modulation of the Expression of IGF2 and Other Cell-Cycle Regulators
The molecular mechanisms that orchestrate the exit from pluripotency, cell cycle progression, and lineage-specific differentiation in human pluripotent stem cells (hPSCs) are poorly understood. RELB, a key protein in the noncanonical nuclear factor-kappaB (NFκB) signaling pathway, was previously implicated in controlling the switch between human embryonic stem cell (hESC) proliferation and differentiation. Here, we show that RELB enhances the proliferation of hESCs and human-induced pluripotent stem cells (hiPSCs) without affecting their pluripotency. We demonstrate that RELB does this by interacting with two RNA-binding proteins LIN28A and IMP3 (IGF2 mRNA-binding protein 3); further, these interactions control mRNA levels and protein expression of insulin-like growth factor 2 (IGF2) and key cell-cycle genes. Finally, after stress, these proteins co-localize in stress granules in hESCs and iPSCs. Our data identify RELB as a novel regulator of hPSC proliferation, and suggest a new function for RELB, in addition to its widely accepted role as a transcription factor, that involves recruitment of IMP3 and LIN28 to the cytosolic mRNA translation-control domains for post-transcriptional modulation of IGF2 and cell-cycle gene expression.
Get full access to this article
View all access options for this article.
References
1.
PeraM, ReubinoffB and TrounsonA. (2000). Human embryonic stem cells. J Cell Sci, 113:5–10.
2.
PeraMF, BennettW and CerrettiDP. (1997). Expression of CD30 and CD30 ligand in cultured cell lines from human germ-cell tumors. Lab Invest, 76:497–504.
3.
ThomsonJA, Itskovitz-EldorJ, ShapiroSS, WaknitzMA, SwiergielJJ, MarshallVS and JonesJM. (1998). Embryonic stem cell lines derived from human blastocysts. Science, 282:1145–1147.
4.
TakahashiK and YamanakaS. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126:663–676.
5.
HawksworthOA, CoulthardLG, TaylorSM, WolvetangEJ and WoodruffTM. (2014). Brief report: complement C5a promotes human embryonic stem cell pluripotency in the absence of FGF2. Stem Cells, 32:3278–3284.
6.
OvchinnikovDA, TurnerJP, TitmarshDM, ThakarNY, SinDC, Cooper-WhiteJJ and WolvetangEJ. (2012). Generation of a human embryonic stem cell line stably expressing high levels of the fluorescent protein mCherry. World J Stem Cells, 4:71–79.
7.
BhattacharyaB, MiuraT, BrandenbergerR, MejidoJ, LuoY, YangAX, JoshiBH, GinisI, ThiesRS, AmitM, et al. (2004). Gene expression in human embryonic stem cell lines: unique molecular signature. Blood, 103:2956–2964.
8.
RaoRR, CalhounJD, QinXT, RekayaR, ClarkJK and SticeSL. (2004). Comparative transcriptional profiling of two human embryonic stem cell lines. Biotechnol Bioeng, 88:273–286.
9.
SatoN, SanjuanIM, HekeM, UchidaM, NaefF and BrivanlouAH. (2003). Molecular signature of human embryonic stem cells and its comparison with the mouse. Dev Biol, 260:404–413.
10.
LightenAD, HardyK, WinstonRML and MooreGE. (1997). Expression of mRNA for the insulin-like growth factors and their receptors in human preimplantation embryos. Mol Reprod Dev, 47:134–139.
11.
ChiMM-Y, SchleinAL and MoleyKH. (2000). High insulin-like growth factor 1 (IGF-1) and insulin concentrations trigger apoptosis in the mouse blastocyst via down-regulation of the IGF-1 receptor. Endocrinology, 141:4784–4792.
12.
WeksbergR, ShenDR, FeiYL, SongQL and SquireJ. (1993). Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome. Nat Genet, 5:143–150.
13.
SussenbachJS. (1989). The gene structure of the insulin-like growth factor family. Prog Growth Factor Res, 1:33–48.
14.
BalagopalV and ParkerR. (2009). Polysomes, P bodies and stress granules: states and fates of eukaryotic mRNAs. Curr Opin Cell Biol, 21:403–408.
15.
Valencia-SanchezMA, LiuJ, HannonGJ and ParkerR. (2006). Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev, 20:515–524.
NielsenJ, ChristiansenJ, Lykke-AndersenJ, JohnsenAH, WewerUM and NielsenFC. (1999). A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol, 19:1262–1270.
18.
NielsenFC, NielsenJ and ChristiansenJ. (2001). A family of IGF-II mRNA binding proteins (IMP) involved in RNA trafficking. Scand J Clin Lab Invest Suppl, 234:93–99.
19.
BalzerE and MossEG. (2007). Localization of the developmental timing regulator Lin28 to mRNP complexes, P-bodies and stress granules. RNA Biol, 4:16–25.
20.
PolesskayaA, CuvellierS, NaguibnevaI, DuquetA, MossEG and Harel-BellanA. (2007). Lin-28 binds IGF-2 mRNA and participates in skeletal myogenesis by increasing translation efficiency. Genes Dev, 21:1125–1138.
21.
RybakA, FuchsH, SmirnovaL, BrandtC, PohlEE, NitschR and WulczynFG. (2008). A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment. Nat Cell Biol, 10:987–993.
22.
PiskounovaE, ViswanathanSR, JanasM, LaPierreRJ, DaleyGQ, SlizP and GregoryRI. (2008). Determinants of microRNA processing inhibition by the developmentally regulated RNA-binding protein Lin28. J Biol Chem, 283:21310–21314.
23.
HeoI, JooC, ChoJ, HaM, HanJ and KimVN. (2008). Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA. Mol Cell, 32:276–284.
24.
NewmanMA, ThomsonJM and HammondSM. (2008). Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing. RNA, 14:1539–1549.
25.
ViswanathanSR, DaleyGQ and GregoryRI. (2008). Selective blockade of microRNA processing by Lin28. Science, 320:97–100.
26.
RoushS and SlackFJ. (2008). The let-7 family of microRNAs. Trends Cell Biol, 18:505–516.
27.
HaganJP, PiskounovaE and GregoryRI. (2009). Lin28 recruits the TUTase Zcchc11 to inhibit let-7 maturation in mouse embryonic stem cells. Nat Struct Mol Biol, 16:1021–1025.
28.
HeoI, JooC, KimY-K, HaM, YoonM-J, ChoJ, YeomK-H, HanJ and KimVN. (2009). TUT4 in concert with Lin28 suppresses microRNA biogenesis through pre-microRNA uridylation. Cell, 138:696–708.
29.
LehrbachNJ, ArmisenJ, LightfootHL, MurfittKJ, BugautA, BalasubramanianS and MiskaEA. (2009). LIN-28 and the poly(U) polymerase PUP-2 regulate let-7 microRNA processing in Caenorhabditis elegans. Nat Struct Mol Biol, 16:1016–1020.
30.
LiN, ZhongX, LinX, GuoJ, ZouL, TanyiJL, ShaoZ, LiangS, WangL-P, et al. (2012). Lin-28 homologue A (LIN28A) promotes cell cycle progression via regulation of cyclin-dependent kinase 2 (CDK2), cyclin D1 (CCND1), and cell division cycle 25 homolog A (CDC25A) expression in cancer. J Biol Chem, 287:17386–17397.
31.
ViswanathanSR, PowersJT, EinhornW, HoshidaY, NgTL, ToffaninS, O'SullivanM, LuJ, PhillipsLA, et al. (2009). Lin28 promotes transformation and is associated with advanced human malignancies. Nat Genet, 41:843–848.
32.
CimadamoreF, Amador-ArjonaA, ChenC, HuangCT and TerskikhAV. (2013). SOX2-LIN28/let-7 pathway regulates proliferation and neurogenesis in neural precursors. Proc Natl Acad Sci U S A, 110:E3017–E3026.
33.
Shyh-ChangN and DaleyGeorge Q. (2013). Lin28: primal regulator of growth and metabolism in stem cells. Cell Stem Cell, 12:395–406.
34.
SunS-C. (2010). Controlling the fate of NIK: a central stage in noncanonical NF-{kappa}B signaling. Sci Signal, 3:pe18
35.
RazaniB and ChengG. (2010). NF-{kappa}B: much learned, much to learn. Sci Signal, 3:pe29
36.
LiM, ZhangX, ZhengX, LianD, FengB, VladauC, SuzukiM, PengT, ZhongR and MinW-P. (2006). Immune modulation and tolerance induction by Relb-silenced dendritic cells. Transplantation, 82:311
37.
HaydenMS and GhoshS. (2008). Shared principles in NF-κB signaling. Cell, 132:344–362.
38.
OeckinghausA and GhoshS. (2009). The NF-κB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol, 1:a000034
39.
ThakarNY, OvchinnikovDA, HastieML, KobeB, GormanJJ and WolvetangEJ. (2015). TRAF2 recruitment via T61 in CD30 drives NFκB activation and enhances hESC survival and proliferation. Mol Biol Cell, 26:993–1006.
40.
YangC, AtkinsonSP, VilellaF, LloretM, ArmstrongL, MannDA and LakoM. (2010). Opposing putative roles for canonical and noncanonical NFκB signaling on the survival, proliferation, and differentiation potential of human embryonic stem cells. Stem Cells, 28:1970–1980.
41.
SearleBC. (2010). Scaffold: a bioinformatic tool for validating MS/MS-based proteomic studies. Proteomics, 10:1265–1269.
42.
KellerA, NesvizhskiiAI, KolkerE and AebersoldR. (2002). Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem, 74:5383–5392.
43.
NesvizhskiiAI, KellerA, KolkerE and AebersoldR. (2003). A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem, 75:4646–4658.
44.
LivakKJ and SchmittgenTD. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods, 25:402–408.
45.
BriggsJA, SunJ, ShepherdJ, OvchinnikovDA, ChungTL, NaylerSP, KaoLP, MorrowCA, ThakarNY, et al. (2012). Integration-free induced pluripotent stem cells model genetic and neural developmental features of down syndrome etiology. Stem Cells, 31:467–478.
46.
GartnerW, RossbacherJ, ZierhutB, DanevaT, BaseW, WeisselM, WaldhauslW, PasternackMS and WagnerL. (2003). The ATP-dependent helicase RUVBL1/TIP49a associates with tubulin during mitosis. Cell Motil Cytoskeleton, 56:79–93.
47.
YangR, WeberDJ and CarrierF. (2006). Post-transcriptional regulation of thioredoxin by the stress inducible heterogenous ribonucleoprotein A18. Nucleic Acids Res, 34:1224–1236.
48.
LeffersH, DejgaardK and CelisJE. (1995). Characterisation of two major cellular poly(rC)-binding human proteins, each containing three K-homologous (KH) domains. Eur J Biochem, 230:447–453.
49.
Leung AnthonyKL, VyasS, RoodJE, BhutkarA, SharpPA and ChangP. (2011). Poly(ADP-ribose) regulates stress responses and microRNA activity in the cytoplasm. Mol Cell, 42:489–499.
50.
ThakarNY and WolvetangEJ. (2015). Ascorbate as a modulator of the epigenome. In: Nutrition and Epigenetics. HoE, DomannF, eds. CRC Press, Boca Raton, FL, pp 199–218.
51.
ChungT-L, ThakarNY and WolvetangEJ. (2011). Genetic and epigenetic instability of human pluripotent stem cells. Open Stem Cell J, 3:52–61.
52.
ChungT-L, TurnerJP, ThakerNY, KolleG, Cooper-WhiteJJ, GrimmondSM, PeraMF and WolvetangEJ. (2010). Ascorbate promotes epigenetic activation of CD30 in human embryonic stem cells. Stem Cells, 28:1782–1793.
53.
CougotN, BabajkoS and SéraphinB. (2004). Cytoplasmic foci are sites of mRNA decay in human cells. J Cell Biol, 165:31–40.
54.
KedershaN, StoecklinG, AyodeleM, YaconoP, Lykke-AndersenJ, FritzlerMJ, ScheunerD, KaufmanRJ, GolanDE and AndersonP. (2005). Stress granules and processing bodies are dynamically linked sites of mRNP remodeling. J Cell Biol, 169:871–884.
55.
TeixeiraD, ShethU, Valencia-SanchezMA, BrenguesM and ParkerR. (2005). Processing bodies require RNA for assembly and contain nontranslating mRNAs. RNA, 11:371–382.
56.
MolletS, CougotN, WilczynskaA, DautryF, KressM, BertrandE and WeilD. (2008). Translationally repressed mRNA transiently cycles through stress granules during stress. Mol Biol Cell, 19:4469–4479.
57.
RyseckRP, BullP, TakamiyaM, BoursV, SiebenlistU, DobrzanskiP and BravoR. (1992). RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B. Mol Cell Biol, 12:674–684.
58.
SolanN, MiyoshiH, CarmonaE, BrenG and PayaC. (2002). RelB cellular regulation and transcriptional activity are regulated by p100. J Biol Chem, 277:1405–1418.
59.
MarienfeldR, MayM, BerberichI, SerflingE, GhoshS and NeumannM. (2003). RelB forms transcriptionally inactive complexes with RelA/p65. J Biol Chem, 278:19852–19860.
60.
YilmazZ, WeihD, SivakumarV and WeihF. (2003). RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF. EMBO J, 22:121–130.
61.
DemiccoEG, KavanaghKT, Romieu-MourezR, WangX, ShinSR, Landesman-BollagE, SeldinDC and SonensheinGE. (2005). RelB/p52 NF-κB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IκB-α expression and promote carcinogenesis of the mammary gland. Mol Cell Biol, 25:10136–10147.
62.
YunJ, TsaoM-S and DerS. (2011). Differential utilization of NF-kappaB RELA and RELB in response to extracellular versus intracellular polyIC stimulation in HT1080 cells. BMC Immunol, 12:15
63.
NelsonDE, IhekwabaAEC, ElliottM, JohnsonJR, GibneyCA, ForemanBE, NelsonG, SeeV, HortonCA, et al. (2004). Oscillations in NF-κB signaling control the dynamics of gene expression. Science, 306:704–708.
64.
HatB, PuszynskiK and LipniackiT. (2009). Exploring mechanisms of oscillations in p53 and nuclear factor-kappa B systems. IET Syst Biol, 3:342–355.
65.
MengelB, HunzikerA, PedersenL, TrusinaA, JensenMH and KrishnaS. (2010). Modeling oscillatory control in NF-[kappa]B, p53 and Wnt signaling. Curr Opin Genet Dev, 20:656–664.
66.
LuL, KatsarosD, ShaverdashviliK, QianB, WuY, de la LongraisIAR, PretiM, MenatoG and YuH. (2009). Pluripotent factor lin-28 and its homologue lin-28b in epithelial ovarian cancer and their associations with disease outcomes and expression of let-7a and IGF-II. Eur J Cancer, 45:2212–2218.
67.
Flores-RomoL, BjörckP, DuvertV, van KootenC, SaelandS and BanchereauJ. (1997). CD40 Ligation on human cord blood CD34+ hematopoietic progenitors induces their proliferation and differentiation into functional dendritic cells. J Exp Med, 185:341–350.
68.
LeeDW, RamakrishnanD, ValentaJ, ParneyIF, BaylessKJ and SitcheranR. (2013). The NF-κB RelB protein is an oncogenic driver of mesenchymal glioma. PLoS One, 8:e57489
69.
SchneiderG, SaurD, SivekeJT, FritschR, GretenFR and SchmidRM. (2006). IKKalpha controls p52/RelB at the skp2 gene promoter to regulate G1- to S-phase progression. EMBO J, 25:3801–3812.
70.
KongD, BanerjeeS, AhmadA, LiY, WangZ, SethiS and SarkarFH. (2010). Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells. PLoS One, 5:e12445
71.
HudsonJ, TitmarshD, HidalgoA, WolvetangE and Cooper-WhiteJ. (2012). Primitive cardiac cells from human embryonic stem cells. Stem Cells Dev, 21:1513–1523.
72.
ChambersSM, FasanoCA, PapapetrouEP, TomishimaM, SadelainM and StuderL. (2009). Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol, 27:275–280.
73.
KimDS, LeeJS, LeemJW, HuhYJ, KimJY, KimHS, ParkIH, DaleyGQ, HwangDY and KimDW. (2010). Robust enhancement of neural differentiation from human ES and iPS cells regardless of their innate difference in differentiation propensity. Stem Cell Rev, 6:270–281.
74.
AngH-L and TergaonkarV. (2007). Notch and NFκB signaling pathways: do they collaborate in normal vertebrate brain development and function?. Bioessays, 29:1039–1047.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
